Intelligence · Clinical Development
Pipeline search results
Programs matching “epithelial” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 43 pipeline programs matching "epithelial" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
2024/4031
The George Institute
Patients with primary HPV high-grade squamous intra-epithelial lesions (HSIL) at any site (vulvar VIN, vaginal VaIN, penile (PeIN), cervical CIN, anal AIN) at the time of treatment.
1 trial -
213350/3000-03-005
TESARO Bio Netherlands B.V.
Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer
1 trial -
ALKS 4230-007
Wuhan Createrna Science and Technology Co., Ltd
Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
1 trial -
CISPLATIN
Ningbo Cancer Hospital
Ovarian epithelial cancer : intraperitoneal resectable relapse
1 trial -
CO-338-087
pharmaand GmbH
Ovarian epithelial cancer, Malignant peritoneal neoplasm, advanced (FIGO stage III-IV), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer (who responded to front-line platinum-based chemotherapy), Fallopian tube cancer
1 trial -
CORT125134-556
CORCEPT THERAPEUTICS INC
Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
1 trial -
D8991C00001
AstraZeneca AB
Advanced Platinum-resistant Epithelial Ovarian Cancer
1 trial -
DUO-O/D081RC00001
AstraZeneca AB
Newly diagnosed advanced (FIGO stage III-IV) high grade epithelial ovarian, fallopian or primary peritoneal cancer
1 trial -
Imiquimod
United Therapeutics Europe Ltd
Cervical Intraepithelial Neoplasia
1 trial -
Mirvetuximab Soravtansine
AbbVie
Epithelial Ovarian Cancer
1 trial -
NGF-PCED-301
Dompe' Farmaceutici S.p.A.
Persistent Corneal Epithelial Defect (PCED)
1 trial -
cisplatin i.p.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epithelial Carcinoma, Ovarian
1 trial -
nab-paclitaxel combined with carboplatin
The First People's Hospital of Lianyungang
Epithelial Ovarian Carcinoma Stage III
1 trial -
neoadjuvant chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epithelial Ovarian Cancer
1 trial -
-, Pred Forte 10 mg/ml colirio en suspensión
AbbVie Deutschland GmbH & Co. KG
platinum-resistant advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers.
1 trial -
HPV DNA Plasmids Therapeutic Vaccine VGX-3100
INOVIO PHARMACEUTICALS, INC.
Anal Intraepithelial Neoplasia
1 trial -
IMGN151-1001
AbbVie Deutschland GmbH & Co. KG
Recurrent endometrial cancer, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer (EOC), recurrent cervical cancer
1 trial -
MS201924_0002
Merck Sharp and Dohme
Epithelial ovarian cancer that progressed on prior PARP inhibitor therapy
1 trial -
OBG PED-001
KIORA PHARMACEUTICALS INC
Persistent Corneal Epithelial Defect
1 trial -
STRO-002-GM3
SUTRO BIOPHARMA, INC.
Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)
1 trial -
Toripalimab + Chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thymic Epithelial Tumor
1 trial -
VGX 3100
INOVIO PHARMACEUTICALS, INC.
Cervical Intraepithelial Neoplasia
1 trial -
VGX-3100
INOVIO PHARMACEUTICALS, INC.
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1 trial -
WO42178
Hoffmann-La Roche
Persistent or Recurrent Rare Epithelial Ovarian Tumors
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.